ATE426662T1 - Feedback resistante mevalonate kinase - Google Patents

Feedback resistante mevalonate kinase

Info

Publication number
ATE426662T1
ATE426662T1 AT04736497T AT04736497T ATE426662T1 AT E426662 T1 ATE426662 T1 AT E426662T1 AT 04736497 T AT04736497 T AT 04736497T AT 04736497 T AT04736497 T AT 04736497T AT E426662 T1 ATE426662 T1 AT E426662T1
Authority
AT
Austria
Prior art keywords
mevalonate kinase
feedback resistant
resistant mevalonate
vectors
producing
Prior art date
Application number
AT04736497T
Other languages
English (en)
Inventor
Renyunan Bai
Mbelin Markus H
Martin Lehmann
Rual Lopez-Ulibarri
Markus Wyss
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE426662T1 publication Critical patent/ATE426662T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04736497T 2003-06-12 2004-06-10 Feedback resistante mevalonate kinase ATE426662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03012294 2003-06-12

Publications (1)

Publication Number Publication Date
ATE426662T1 true ATE426662T1 (de) 2009-04-15

Family

ID=33547583

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04736497T ATE426662T1 (de) 2003-06-12 2004-06-10 Feedback resistante mevalonate kinase

Country Status (9)

Country Link
US (1) US7422884B2 (de)
EP (1) EP1631664B1 (de)
JP (1) JP4643569B2 (de)
KR (1) KR101190897B1 (de)
CN (1) CN1806042B (de)
AT (1) ATE426662T1 (de)
DE (1) DE602004020218D1 (de)
ES (1) ES2323175T3 (de)
WO (1) WO2004111214A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4841562B2 (ja) * 2004-12-14 2011-12-21 ディーエスエム アイピー アセッツ ビー．ブイ． 改良型メバロネートキナーゼ
KR101482081B1 (ko) 2005-03-18 2015-01-13 마이크로비아 인크. 유질 효모와 진균 내에서 카로티노이드의 생산
WO2008039499A2 (en) 2006-09-26 2008-04-03 The Regents Of The University Of California Production of isoprenoids and isoprenoid precursors
EP2078092A2 (de) 2006-09-28 2009-07-15 Microbia, Inc. Herstellung von carotenoiden in öliger hefe und pilzen
JP2009000046A (ja) * 2007-06-21 2009-01-08 Hitachi Zosen Corp トチュウのメバロン酸経路の酵素をコードする遺伝子
SG162265A1 (en) 2007-12-13 2010-07-29 Danisco Us Inc Compositions and methods for producing isoprene
MX2010011706A (es) 2008-04-23 2011-03-15 Danisco Us Inc Variantes de isopreno-sintasa para produccion microbiana mejorada de isopreno.
EP2157174A1 (de) 2008-08-12 2010-02-24 DSM IP Assets B.V. Erhöhte Produktion von Pantothenate (Vitamin B5)
MY156562A (en) 2008-09-15 2016-02-26 Danisco Us Inc Increased isoprene production using the archaeal lower mevalonate pathway
WO2010124146A2 (en) 2009-04-23 2010-10-28 Danisco Us Inc. Three-dimensional structure of isoprene synthase and its use thereof for generating variants
EP2336310A1 (de) 2009-12-16 2011-06-22 Isobionics B.V. Valencensynthase
CN103179850B (zh) 2010-06-02 2016-03-16 沃维公司 甜菊糖苷的重组生产
WO2012014228A1 (en) 2010-07-28 2012-02-02 Abhishek Narain Singh A method to by-pass allosteric domain activity of an enzyme so as to alter its feedback or feed-forward inhibition or activation
US20120045812A1 (en) * 2010-08-06 2012-02-23 Danisco Us Inc. PRODUCTION OF ISOPRENE UNDER NEUTRAL pH CONDITIONS
JP2014502148A (ja) 2010-10-27 2014-01-30 ダニスコ・ユーエス・インク イソプレン生産の向上を目的としたイソプレン合成酵素変異体
WO2012175574A1 (en) 2011-06-21 2012-12-27 Dsm Ip Assets B.V. Increased pantothenate (vitamin b5) production
EP2537926A1 (de) 2011-06-21 2012-12-26 Isobionics B.V. Valencensynthase
WO2012175575A2 (en) 2011-06-21 2012-12-27 Dsm Ip Assets B.V. Increased vitamin b5 production
WO2013022799A1 (en) 2011-08-05 2013-02-14 Danisco Us Inc. PRODUCTION OF ISOPRENOIDS UNDER NEUTRAL pH CONDITIONS
CN103732753B (zh) 2011-08-08 2018-03-30 埃沃尔瓦公司 甜菊醇糖苷类的重组生产
CN103205432B (zh) * 2012-01-11 2015-06-10 安徽医科大学第一附属医院 弥散型浅表性光线性汗孔角化症(dsap)相关基因
US9163263B2 (en) 2012-05-02 2015-10-20 The Goodyear Tire & Rubber Company Identification of isoprene synthase variants with improved properties for the production of isoprene
JP6379112B2 (ja) 2013-02-06 2018-08-22 エヴォルヴァ エスアー．Ｅｖｏｌｖａ Ｓａ． レバウディオサイドｄおよびレバウディオサイドｍの改良された産生方法
AU2014213918B2 (en) 2013-02-11 2017-11-09 Danstar Ferment Ag Efficient production of steviol glycosides in recombinant hosts
RU2014112066A (ru) 2014-03-28 2015-10-10 Адзиномото Ко., Инк. Способ получения мономерного изопрена
BR112017002783A2 (pt) 2014-08-11 2017-12-19 Evolva Sa produção de glicosídeos de esteviol em hospedeiros recombinantes
KR20170052647A (ko) 2014-09-09 2017-05-12 에볼바 에스아 재조합 숙주에서 스테비올 글리코시드의 생성
BR112017016338A2 (pt) 2015-01-30 2018-03-27 Evolva Sa produção de glicosídeos de esteviol em hospedeiros recombinantes
EP3862426A3 (de) 2015-03-16 2021-11-17 DSM IP Assets B.V. Udp-glycosyltransferasen
CA2995067A1 (en) 2015-08-07 2017-02-16 Evolva Sa Production of steviol glycosides in recombinant hosts
CA3020671A1 (en) 2016-04-13 2017-10-19 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2017198682A1 (en) 2016-05-16 2017-11-23 Evolva Sa Production of steviol glycosides in recombinant hosts
CN110100006A (zh) 2016-11-07 2019-08-06 埃沃尔瓦公司 重组宿主中甜菊糖苷的生产
NL2018457B1 (en) 2017-03-02 2018-09-21 Isobionics B V Santalene Synthase
NL2019473B1 (en) 2017-09-01 2019-03-11 Isobionics B V Terpene Synthase producing patchoulol and elemol, and preferably also pogostol
KR102092075B1 (ko) * 2017-10-27 2020-03-23 경상대학교산학협력단 MmMVK-메발론산 복합체의 3차원 결정 구조 및 기질저해 저항성 돌연변이 메발론산 인산화효소
WO2019113387A1 (en) 2017-12-07 2019-06-13 Zymergen Inc. Engineered biosynthetic pathways for production of (6e)-8-hydroxygeraniol by fermentation
JP2021506316A (ja) 2017-12-21 2021-02-22 ザイマージェン インコーポレイテッド ネペタラクトールオキシドレダクターゼ、ネペタラクトールシンターゼ、及びネペタラクトンを産生する能力がある微生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI250210B (en) 1998-05-06 2006-03-01 Dsm Ip Assets Bv An isolated DNA sequence coding for an enzyme involved in the mevalonate pathway or the pathway from isopentenyl pyrophosphate to farnesyl pyrophosphate
ES2311613T3 (es) 2001-06-06 2009-02-16 Dsm Ip Assets B.V. Produccion mejorada de isoprenoides.

Also Published As

Publication number Publication date
JP4643569B2 (ja) 2011-03-02
KR101190897B1 (ko) 2012-10-12
US7422884B2 (en) 2008-09-09
WO2004111214A1 (en) 2004-12-23
JP2007523612A (ja) 2007-08-23
US20070141685A1 (en) 2007-06-21
DE602004020218D1 (de) 2009-05-07
EP1631664B1 (de) 2009-03-25
EP1631664A1 (de) 2006-03-08
CN1806042B (zh) 2012-07-04
KR20060022692A (ko) 2006-03-10
ES2323175T3 (es) 2009-07-08
CN1806042A (zh) 2006-07-19

Similar Documents

Publication Publication Date Title
ATE426662T1 (de) Feedback resistante mevalonate kinase
ATE500321T1 (de) Verbesserte mevalonatkinase
HK1071572A1 (en) PyrazoloÄ1,5-AÜpyrimidine compounds as cyclin dependent kinase inhibitors
AU2003221753A1 (en) Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
TW200736231A (en) Substituted pyrimidines
WO2005084305A3 (en) Flavonoids
NO20082482L (no) Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer
WO2008033408A3 (en) Methods for identifying compounds that modulate cell signaling and methods employing such compounds
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
HK1080843A1 (en) (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
TW200731094A (en) Extensible meta-data
BR0315233A (pt) Derivados de azaindol como inibidores de p38 cinase
ATE297395T1 (de) 3-(pyrolyllacton)-2-indolinon verbindungen zur verwendung als kinase-hemmstoffe
DE60323749D1 (de) Substituierte pyrroline als kinase inhibitoren
CY1108092T1 (el) Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου με την αναστολη της κινασης aurora
MXPA06003297A (es) Metodo de servicio de certificacion segura.
MY146989A (en) Kinase inhibitors
DE602005023333D1 (de) Kinaseinhibitoren
NO20053395L (no) Framgangsmate for styring av prosess i borehull, bruk av seismisk kommunikasjon.
WO2009054939A8 (en) Cancer classification and methods of use
WO2004043379A3 (en) Chemical compounds
TNSN06099A1 (en) Coding system for security documents
EP1605264A4 (de) Integrierender analysechip mit minimierten reaktoren und dessen anwendung
WO2002066681A3 (en) Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
WO2023177356A3 (en) Compounds and method for pkmyt1 inhibition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties